GBA1 and Parkinson disease: Moreover, significant reduction in GCase activity and protein levels is also observed in the brains of Parkinson’s disease patients without GBA1 mutations (Gegg et al., 2012; Murphy and Halliday, 2014), indicating the potential importance of GCase in the development of idiopathic Parkinson’s disease.